Shanghai - Delayed Quote CNY

Shanghai Sanyou Medical Co., Ltd (688085.SS)

20.58
-0.21
(-1.01%)
At close: May 16 at 3:00:03 PM GMT+8
Loading Chart for 688085.SS
  • Previous Close 20.79
  • Open 20.52
  • Bid 20.57 x --
  • Ask 20.58 x --
  • Day's Range 20.33 - 21.11
  • 52 Week Range 15.10 - 24.22
  • Volume 2,505,138
  • Avg. Volume 2,144,297
  • Market Cap (intraday) 5.719B
  • Beta (5Y Monthly) -0.24
  • PE Ratio (TTM) 187.09
  • EPS (TTM) 0.11
  • Earnings Date --
  • Forward Dividend & Yield 0.08 (0.38%)
  • Ex-Dividend Date Jun 11, 2024
  • 1y Target Est --

Shanghai Sanyou Medical Co., Ltd. researches, develops, manufactures, and sells orthopedics implants in China. The company offers spinal and trauma implants under Tytus and Sanyou brand. Its spinal products comprise anterior cervical plate, anterior thoracolumbar, posterior cervical, posterior thoracolumbar, and z-minimally invasive products; and trauma implants, including shoulder and elbow system, hip and pelvis system, knee system, foot and ankle, knee system, and palm and wrist systems. It also offers sports medicine. Shanghai Sanyou Medical Co., Ltd. was founded in 2005 and is based in Shanghai, China.

www.sanyoumed.com

--

Full Time Employees

December 31

Fiscal Year Ends

Recent News: 688085.SS

View More

Performance Overview: 688085.SS

Trailing total returns as of 5/16/2025, which may include dividends or other distributions. Benchmark is SSE Composite Index (000001.SS) .

YTD Return

688085.SS
2.88%
SSE Composite Index (000001.SS)
0.47%

1-Year Return

688085.SS
15.78%
SSE Composite Index (000001.SS)
7.85%

3-Year Return

688085.SS
23.36%
SSE Composite Index (000001.SS)
9.56%

5-Year Return

688085.SS
61.38%
SSE Composite Index (000001.SS)
17.40%

Compare To: 688085.SS

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 688085.SS

View More

Valuation Measures

Annual
As of 5/16/2025
  • Market Cap

    5.72B

  • Enterprise Value

    5.34B

  • Trailing P/E

    187.09

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    10.26

  • Price/Book (mrq)

    2.82

  • Enterprise Value/Revenue

    11.03

  • Enterprise Value/EBITDA

    112.69

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    5.43%

  • Return on Assets (ttm)

    0.98%

  • Return on Equity (ttm)

    1.26%

  • Revenue (ttm)

    482.65M

  • Net Income Avi to Common (ttm)

    26.22M

  • Diluted EPS (ttm)

    0.11

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    425.18M

  • Total Debt/Equity (mrq)

    2.07%

  • Levered Free Cash Flow (ttm)

    --

Research Analysis: 688085.SS

View More

Company Insights: 688085.SS

Research Reports: 688085.SS

View More

People Also Watch